The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global direct fed microbials market size reached US$ 1.18 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.12% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Direct-fed microbials (DFMs) are feed supplements that contain live and naturally occurring bacteria to improve the health and productivity of animals. They lower the pH, reduce enteric pathogens, and stimulate intestinal cell proliferation, which maintains the gut integrity of animals. They detoxify undesirable compounds, such as lactic acid and mycotoxins, to boost the immune system. They also help provide microbial balance in the digestive tract by producing high levels of beneficial enzymes, such as alpha amylase, cellulase, and protease. At present, there is a rise in the demand for DFMs due to the growing prevalence of different diseases among animals across the globe.
The rising demand for poultry meat due to its high protein content, along with the growing livestock population around the world, represents one of the key factors driving the market. Besides this, the increasing awareness among the masses about the benefits of DFMs, such as enhancing metabolism, maintaining microbial flora in the intestine, ammonia production, and neutralizing enterotoxin, is offering lucrative growth opportunities to industry investors. Moreover, there is an increase in the replacement of antibiotic growth promoters with direct-fed microbials to reduce the risk of transmitting drug-resistant bacteria to humans. This, along with the burgeoning livestock industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce blockchain and the internet of things (IoT) technologies for managing the procurement, processing, and distribution of DFM products effectively. They are also focusing on various marketing strategies to expand their market reach. Apart from this, the rising utilization of DFMs to reduce the mortality rate of animals due to clostridial, diarrhea, and gastrointestinal diseases is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global direct fed microbials market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, livestock and form.
Breakup by Product Type:
Breakup by Livestock:
Breakup by Form:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S) and Novus International Inc. (Mitsui & Co. Ltd).
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Livestock, Form, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S) and Novus International Inc. (Mitsui & Co. Ltd).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at